Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma by Nagendra K. Chaturvedi, Sidharth Mahapatra, Varun Kesherwani, Matthew J. Kling, Mamta Shukla, Sutapa Ray, Ranjana Kanchan, Naveenkumar Perumal, Timothy R. McGuire, J. Graham Sharp, Shantaram S. Joshi, Don W. Coulter

Subjects: Get full text

Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue by Lakshmi Prabhu, Matthew Martin, Lan Chen, Özlem Demir, Jiamin Jin, Xiumei Huang, Aishat Motolani, Mengyao Sun, Guanglong Jiang, Harikrishna Nakshatri, Melissa L. Fishel, Steven Sun, Ahmad Safa, Rommie E. Amaro, Mark R. Kelley, Yunlong Liu, Zhong-Yin Zhang, Tao Lu

Subjects: Get full text

Understanding the role of PRMT5 in neuroblastoma by Albayrak, G

Subjects: “…PRMT5…”

PRMT5 Is Required for Bovine Leukemia Virus Infection In Vivo and Regulates BLV Gene Expression, Syncytium Formation, and Glycosylation In Vitro by Wlaa Assi, Tomoya Hirose, Satoshi Wada, Ryosuke Matsuura, Shin-nosuke Takeshima, Yoko Aida

Subjects: Get full text

Targeting PRMT5 enhances the radiosensitivity of tumor cells grown in vitro and in vivo by Charlotte Degorre, Steven Lohard, Christina N. Bobrek, Komal N. Rawal, Skyler Kuhn, Philip J. Tofilon

Subjects: “…PRMT5…”
Get full text

Design, Synthesis and Biological Evaluation of Novel and Potent Protein Arginine Methyltransferases 5 Inhibitors for Cancer Therapy by Yixuan Tang, Shihui Huang, Xingxing Chen, Junzhang Huang, Qianwen Lin, Lei Huang, Shuping Wang, Qihua Zhu, Yungen Xu, Yi Zou

Subjects: Get full text

Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer by Yaxun Guo, Yuzhan Li, Zhongmei Zhou, Lei Hou, Wenjing Liu, Wenlong Ren, Dazhao Mi, Jian Sun, Xueqin Dai, Yingying Wu, Zhuo Cheng, Tingyue Wu, Qianmei Luo, Cong Tian, Fubing Li, Zhigang Yu, Yihua Chen, Ceshi Chen

Subjects: Get full text

PRMT5 inhibition attenuates cartilage degradation by reducing MAPK and NF-κB signaling by Yonghui Dong, Ping Wang, Yongguang Yang, Jincheng Huang, Zhipeng Dai, Wendi Zheng, Zhen Li, Zheng Yao, Hongjun Zhang, Jia Zheng

Subjects: Get full text

Tadalafil increases the antitumor activity of 5-FU through inhibiting PRMT5-mediated glycolysis and cell proliferation in colorectal cancer by Yao Shen, Pan Zhao, Kewei Dong, Jiajia Wang, Huichen Li, Mengyang Li, Ruikai Li, Suning Chen, Yuxia Shen, Zhiyu Liu, Mianjiao Xie, Peng Shen, Jian Zhang

Subjects: Get full text

Application and research progress of synthetic lethality in the development of anticancer therapeutic drugs by Xiaoliang Gong, Chunxi Liu, Haoyang Tang, Song Wu, Qingyun Yang

Subjects: Get full text

PRMT5 regulates ovarian follicle development by facilitating Wt1 translation by Min Chen, Fangfang Dong, Min Chen, Zhiming Shen, Haowei Wu, Changhuo Cen, Xiuhong Cui, Shilai Bao, Fei Gao

Subjects: “…PRMT5…”
Get full text

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer by Coralie Poulard, Thuy Ha Pham, Youenn Drouet, Julien Jacquemetton, Ausra Surmielova, Loay Kassem, Benoite Mery, Christine Lasset, Jonathan Reboulet, Isabelle Treilleux, Elisabetta Marangoni, Olivier Trédan, Muriel Le Romancer

Subjects: Get full text

Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach by Philip Vlummens, Philip Vlummens, Stefaan Verhulst, Kim De Veirman, Anke Maes, Eline Menu, Jérome Moreaux, Jérome Moreaux, Jérome Moreaux, Hugues De Boussac, Nicolas Robert, Elke De Bruyne, Dirk Hose, Fritz Offner, Karin Vanderkerken, Ken Maes, Ken Maes

Subjects: Get full text

Carcinogenesis and Prognostic Utility of Arginine Methylation-Related Genes in Hepatocellular Cancer by Waleed Ali, Weirui Xiao, Henry Hoang, Vincent Cali, Andre Kajdacsy-Balla

Subjects: Get full text

Prognostic potential of PRMT5 and DSG2 proteins in pre-malignant cervical lesions by Bibiana Krajňáková, Desanka Výbohová, Sandra Hurta-Csizmár, Veronika Mešťanová, Marian Adamkov

Subjects: Get full text

PRMT5 promotes chemotherapy‐induced neuroendocrine differentiation in NSCLC by Qi Shen, Yi Liu, Xuehong Deng, Chang‐Deng Hu

Subjects: Get full text

The PRMT5-LSD1 axis confers Slug dual transcriptional activities and promotes breast cancer progression by Jianchao Zhang, Xiaokai Fan, Yunfan Zhou, Liang Chen, Hai Rao

Subjects: Get full text

Magnetic-Driven Hydrogel Microrobots Selectively Enhance Synthetic Lethality in MTAP-Deleted Osteosarcoma by Haoran Mu, Haoran Mu, Chenlu Liu, Qi Zhang, Huanliang Meng, Huanliang Meng, Shimin Yu, Ke Zeng, Jing Han, Jing Han, Xinmeng Jin, Xinmeng Jin, Shi Shi, Peiyao Yu, Tianlong Li, Jing Xu, Jing Xu, Yingqi Hua, Yingqi Hua

Subjects: Get full text

TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers by Kimberly J. Briggs, Kevin M. Cottrell, Matthew R. Tonini, Alice Tsai, Minjie Zhang, Douglas A. Whittington, Wenhai Zhang, Steven A. Lombardo, Satoshi Yoda, Erik W. Wilker, Samuel R. Meier, Yi Yu, Teng Teng, Alan Huang, John P. Maxwell

Subjects: “…PRMT5…”
Get full text

Effect of PRMT5 Expression Knockdown on Proliferation, Invasion and Apoptosis of Gastric Cancer Cells and Its Mechanism by GUO Ping, CHEN Jian, WANG Huaqiang, GE Kaijie

Subjects: Get full text